J Pediatr. 2018 Sep 10. pii: S0022-3476(18)30944-2. doi: 10.1016/j.jpeds.2018.07.039. [Epub ahead of print]
Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.
KEYWORDS:
cytotoxic chemotherapy; immunotherapy; minimal residual disease; next-generation sequencing; precision medicine; targeted therapy
- PMID:
- 30213460
- DOI:
- 10.1016/j.jpeds.2018.07.039
No hay comentarios:
Publicar un comentario